Saeho Chong

Saeho Chong has a diverse work experience spanning several prestigious organizations. Saeho is currently the Chief Executive Officer at Elevar Therapeutics since March 2022. Prior to this, they held various roles at Alnylam Pharmaceuticals from 2017 to 2022, including Vice President of DMPK and Bioanalysis and Senior Director of DMPK. In 2016, they worked as a Clinical Pharmacologist at the FDA. From 2012 to 2014, Saeho served as a Director at Takeda Pharmaceuticals. Before that, they were a Professor at Seoul National University from 2009 to 2012. Saeho began their career at Bristol-Myers Squibb in 1990, where they worked as a DMPK professional until 2009.

Saeho Chong has pursued a Doctor of Philosophy (Ph.D.) degree in Pharmaceutics from the University at Buffalo. No specific information about the start or end years of their education is available at this time.